Company Filing History:
Years Active: 2015
Title: Innovations in Cancer Treatment by Yoshitaka Okamoto
Introduction
Yoshitaka Okamoto is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of cancer treatment, particularly focusing on head and neck cancer. His innovative approach aims to enhance the effectiveness of cellular immunotherapy through the use of specialized anti-cancer cell compositions.
Latest Patents
Yoshitaka Okamoto holds a patent for the "Use of anti-cancer cell composition for treatment of head and neck cancer." This patent outlines a method for efficiently delivering cells with anti-tumor activity directly to tumor tissues. The goal is to evoke a stronger anti-tumor reaction and achieve a more effective tumor regression effect. The patent details a method that involves administering an anti-cancer cell composition containing NKT cells activated in vitro, along with an NKT cell-stimulating agent, to treat head and neck cancer.
Career Highlights
Okamoto is affiliated with Chiba University, where he conducts research and develops innovative cancer treatment methodologies. His work has garnered attention for its potential to improve patient outcomes in cancer therapy. He has a strong focus on cellular immunotherapy, which utilizes the body's immune system to fight cancer more effectively.
Collaborations
Yoshitaka Okamoto has collaborated with esteemed colleagues such as Masaru Taniguchi and Shigetoshi Horiguchi. These collaborations have contributed to the advancement of research in cancer treatment and the development of new therapeutic strategies.
Conclusion
Yoshitaka Okamoto's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving therapeutic options for patients with head and neck cancer. His work continues to inspire advancements in the field of oncology.